Furthermore, the ameliorative effect of p85+/? BMDM transfer was significantly reversed by the administration of anti-IL-10 antibody (Fig.?6h and i). The present results demonstrate that p85+/? mice exhibit a reduced susceptibility to DSS-induced acute colitis. Our study suggests that NU6300 a deficiency of PI3K p85 enhances the production of IL-10 in intestinal macrophages, thereby suppressing the development of DSS-induced acute colitis. Introduction Inflammatory bowel disease (IBD), Crohns disease and ulcerative colitis are chronic inflammatory disorders1. IBD has long been recognized to have a genetic basis, and likely involves a response of the immune system to some environmental agents. Abnormalities of intestinal innate immune functions and their relationship to the microbiota have been identified as key properties that characterize the immunogenetic profile of IBD and animal IBD models1. PI3Ks NU6300 have important functions in the innate immune system2. Class IA PI3Ks are a family of heterodimeric enzymes consisting of a regulatory subunit (p85, p55, p50, p85 or p55) and a catalytic subunit (p110, p110 or p110)3. PI3K p85 is the most abundantly expressed among the regulatory subunits and is crucial for the development and functions of various innate immune cells such as dendritic cells4, macrophages5 and mast cells6. Thus, p85-deficient mice showed impaired bacterial clearance in response to acute septic peritonitis6 and failed to develop a food allergy, which were attributed to a deficiency of mast cells in the intestine7. However, the role of the p85 subunit in IBD remains unclear, although several reports have revealed that PI3K plays important roles in the pathogenesis of colitis in humans or mice8, 9. Recently, intestinal macrophages and dendritic cells have been identified as key regulators of immune homeostasis and inflammation in the intestine10. Resident intestinal macrophages can regulate themselves and other immune cells primarily through the spontaneous secretion of IL-10 that ultimately contributes to the prevention of pathological intestinal inflammation11, 12. In contrast, intestinal macrophages in the inflamed mucosa respond to microbial stimulation and produce UBE2J1 large amounts of proinflammatory cytokines that further induce inflammation and damage in the intestine13, 14. In the present study, we investigated the role of PI3K p85 in murine acute colitis, focusing on the cytokine production of macrophages. We demonstrated that p85 hetero-deficient (p85+/?) mice exhibited a reduced susceptibility to dextran sulfate sodium (DSS)-induced acute colitis through an enhancement of IL-10 production in the intestinal macrophages, and high IL-10-producing macrophages protected the mice from the development of DSS-induced acute colitis. Results p85+/? mice show a reduced susceptibility to DSS-induced acute colitis NU6300 To clarify the role of the p85 subunit in colitis, we examined the development of DSS-induced acute colitis in WT and p85+/? mice. Body weight loss was observed on day 4 after the start of DSS treatment in WT colitis mice and was significantly attenuated in p85+/? colitis mice (Fig.?1a; 86.6??1.6% in WT colitis, 98.6??0.9% in p85+/? colitis at day 7). The score of the disease activity index, which was a combination of diarrhea and rectal bleeding, was significantly alleviated in p85+/? colitis mice compared with WT colitis mice (Fig.?1b; 3.9??0.3 in WT, 1.5??0.1 in p85+/? at day 7). Macroscopic observations showed that the shortening of the colon caused by DSS treatment was significantly attenuated in p85+/? colitis mice compared with WT colitis mice (Fig.?1c and d), although the colon length under normal conditions was similar between WT and p85+/? mice (Fig.?1d). As shown in Fig.?1e and f, H&E staining of the colon from DSS-induced WT colitis mice revealed a loss of epithelial integrity and crypt architecture as well as submucosal edema, which were significantly improved in p85+/? colitis mice. The MPO activity NU6300 in the colons of WT NU6300 colitis mice was markedly elevated on day 7 (Fig.?1g). The elevated MPO activity was significantly suppressed in the p85+/? colitis mice. Furthermore, the expression of proinflammatory mediators such as TNF-, IL-1, IL-6 and iNOS mRNA.
